(ATEC) Alphatec Holdings - Ratings and Ratios

Alphatec Holdings Inc (NASDAQ:ATEC) is a medical technology company that specializes in designing, developing, and advancing technologies for the surgical treatment of spinal disorders. The companys product portfolio includes a range of implants, instruments, and biologics that cater to various spinal surgical needs. ATECs innovative product platform, Alpha InformatiX, offers a suite of solutions, including EOS imaging, VEA alignment, SafeOp Neural InformatiX System, and Valence navigation and robotics.

ATECs product offerings can be broadly categorized into three segments: spinal implants and fixation systems, biologics, and surgical access and navigation systems. The companys spinal implants and fixation systems include NanoTec, Invictus, and standalone implants for height restoration and stabilization. Its biologics portfolio comprises 3D ProFuse Osteoconductive Bioscaffold, AlphaGRAFT Demineralized Bone Matrix, BioCORE Moldable Bioactive Graft, and AlphaGRAFT Cellular Bone Matrix. ATECs surgical access and navigation systems include Sigma Prone TransPsoas Access and PTP Patient Positioning Systems, as well as Valence navigation and robotics.

From a sales perspective, ATEC relies on a network of independent sales agents and direct sales representatives to distribute its products. The companys global presence is evident from its international sales, although the majority of its revenue is generated in the United States. With a strong presence in the spinal surgery market, ATEC is well-positioned to capitalize on the growing demand for minimally invasive surgical procedures.

Analyzing the , we observe that ATECs stock price has been trending upwards, with a current price of $11.06. The stock is trading below its 20-day and 50-day simple moving averages (SMA20: $12.35, SMA50: $11.63), indicating a potential short-term correction. However, the stock is above its 200-day simple moving average (SMA200: $9.51), suggesting a long-term uptrend. The average true range (ATR) is $0.51, representing a 4.58% daily price movement. Given the current technical setup, we can expect ATECs stock price to face resistance around $12.35 (SMA20) and support around $9.51 (SMA200).

From a fundamental perspective, ATECs indicates a market capitalization of $1797.93M USD. The companys P/E ratio is not available due to negative earnings. The return on equity (RoE) is -257.63%, suggesting significant losses. However, ATECs innovative product portfolio and expanding global presence may contribute to future revenue growth. By combining the technical and fundamental analysis, we forecast that ATECs stock price will experience a short-term correction, potentially trading between $10.00 and $12.35 in the near term. However, if the company can demonstrate sustained revenue growth and improved profitability, the stock price may surge in the long term, potentially exceeding $15.00.